
EU regulator ‘convinced’ AstraZeneca benefit outweighs risk
India Today
The difficulty of the decision was clear in Thailand, the first country outside Europe to temporarily suspend use of the AstraZeneca vaccine, only to recant on Tuesday — when its prime minister received a dose.
The European Union’s drug regulator insisted Tuesday that there is “no indication” the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients. The European Medicines Agency urged governments not to halt use of the vaccine at a time when the pandemic is still taking thousands of lives each day. And already there are concerns that even brief suspensions could have disastrous effects on confidence in inoculation campaigns the world over, many of which are already struggling to overcome logistical hurdles and widespread hesitancy about vaccines. “We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing COVID-19 with its associated risk of hospitalization and death outweigh the risk of the side effects,” said Emer Cooke, the head of the agency.
The profiles of at least three of China's leading nuclear, missile and radar experts were scrubbed from the website of the Chinese Academy of Engineering, the country's most prestigious academic body. This comes as a series of purges under Premier Xi Jinping's anti-corruption campaign have decimated the upper echelons of China's military and scientific community.

The aircraft had also been used by senior Iranian officials and military figures for both domestic and international travel, and for coordinating with allied countries, the Israeli military said. Meanwhile, Dubai International Airport has resumed flight operations after a temporary suspension of about seven hours caused by a drone strike near a fuel tank facility.











